Monochromosome transfer provides functional evidence for growth-suppressive genes on chromosome 14 in nasopharyngeal carcinoma

Genes Chromosomes and Cancer

Volumn 37, Issue 4, 2003, Pages 359-368

  Cheng, Yue ^a,c   Ko, Josephine M Y ^a   Lung, Hong L ^a   Lo, Paulisally H Y ^a   Stanbridge, Eric J ^b   Lung, Maria L ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MICROSATELLITE DNA;

ALLELE; ANIMAL CELL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CARCINOGENESIS; CARCINOGENICITY; CHROMOSOME 14Q; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; IN VIVO STUDY; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; SLOT BLOT HYBRIDIZATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA; CELL LINE; CELL LINE, TRANSFORMED; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 14; GENE DOSAGE; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; HUMANS; HYBRID CELLS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; MICROSATELLITE REPEATS; NASOPHARYNGEAL NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0038799717     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10228     Document Type: Article

References (54)

1. Bandera CA, Takahashi H, Behbakht K, Liu PC, LiVolsi VA, Benjamin I, Morgan MA, King SA, Rubin SC, Boyd J. 1997. Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma. Cancer Res 57:513-515.
2. Benedict WF, Weissman BE, Mark C, Stanbridge EJ. 1984. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency. Cancer Res 44:3471-3479.
3. Beroud C, Fournet JC, Jeanpierre C, Droz D, Bouvier R, Froger D, Chretien Y, Marechal JM, Weissenbach J, Junien C. 1996. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas. Genes Chromosomes Cancer 17:215-224.
4. Chang WY, Cairns P, Schoenberg MP, Polascik TJ, Sidransky D. 1995. Novel suppressor loci on chromosome 14q in primary bladder cancer. Cancer Res 55:3246-3249.
5. Chen YJ, Ko JY, Chen PJ, Shu CH, Hsu MT, Tsai SF, Lin CH. 1999. Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 25:169-175.
6. Cheng RYS, Lo KW, Huang DP, Tsao SW. 1997. Loss of heterozygosity on chromosome 14 in primary nasopharyngeal carcinoma. Int J Oncol 10:1047-1050.
7. Cheng Y, Poulos NE, Lung ML, Hampton G, Ou B, Lerman MI, Stanbridge EJ. 1998. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc Natl Acad Sci USA 95:3042-3047.
8. Cheng Y, Stanbridge EJ, Kong H, Bengtsson U, Lerman MI, Lung ML. 2000. A functional investigation of tumor suppressor gene activities in a nasopharyngeal carcinoma cell line HONE1 using a monochromosome transfer approach. Genes Chromosomes Cancer 28:82-91.
9. Cheng Y, Chakrabarti R, Garcia-Barcelo M, Ha TJ, Srivatsan ES, Stanbridge EJ, Lung ML. 2002. Mapping of nasopharyngeal carcinoma tumor-suppressive activity to a 1.8-megabase region of chromosome band 11q13. Genes Chromosomes Cancer 34:97-103.
10. Debiec-Rychter M, Sciot R, Pauwels P, Schoenmakers E, Cin PD, Hagemeijer A. 2001. Molecular cytogenetic definition of three distinct chromosome arm 14q deletion intervals in gastrointestinal stromal tumors. Genes Chromosomes Cancer 32:26-32.
11. El-Rifai W, Sarlomo-Rikala M, Andersson LC, Miettinen M, Knuutila S. 2000. High-resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinctive tumor suppressor loci. Genes Chromosomes Cancer 27:387-391.
12. Esteller M, Corn PG, Baylin SB, Herman JG. 2001. A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229.
13. Fang Y, Guan XY, Guo Y, Sham JST, Deng M, Liang Q, Li H, Zhang H, Zhou H, Trent J. 2001. Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization. Genes Chromosomes Cancer 30:254-260.
14. Forsyth NR, Morrison V, Craig NJ, Fitzsimmons SA, Barr NI, Ireland H, Gordon KE, Dowen S, Cuthbert AP, Newbold RF, Bryce SD, Parkinson EK. 2002. Functional evidence for a squamous cell carcinoma mortality gene(s) on human chromosome 4. Oncogene 21:5135-5147.
15. Fujino T, Risinger JI, Collins NK, Liu FS, Nishii H, Takahashi H, Westphal EM, Barrett JC, Sasaki H, Kohler MF, Berchuck A, Boyd J. 1994. Allelotype of endometrial carcinoma. Cancer Res 54:4294-4298.
16. Gazzoli I, Loda M, Garber J, Syngal S, Kolodner RD. 2002. A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res 62:3925-3928.
17. Glaser R, Zhang HY, Yao K, Zhu HC, Wang FX, Li GY, Wen DS, Li YP. 1989. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinoma. Proc Natl Acad Sci USA 86:9524-9528.
18. Herbers J, Schullerus D, Muller H, Kenck C, Chudek J, Weimer J, Bugert P, Kovacs G. 1997. Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas. Genes Chromosomes Cancer 19:29-35.
19. Hoshi M, Otagiri N, Shiwaku HO, Asakawa S, Shimizu N, Kaneko Y, Ohi R, Hayashi Y, Horii A. 2000. Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss. Br J Cancer 82:1801-1807.
20. Hui ABY, Lo KW, Leung SF, Teo P, Fung MKF, To KF, Wong N, Choi PHK, Lee JCK, Huang DP. 1999. Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridization. Int J Cancer 82:498-503.
21. Imreh S, Kholodnyuk I, Allikmetts R, Sranbridge EJ, Zabarovsky ER, Klein G. 1994. Nonrandom loss of human chromosome 3 fragments from mouse-human microcell hybrids following progressive growth in SCID mice. Genes Chromosomes Cancer 11:237-245.
22. Kamnasaran D, Cox DW. 2002. Current status of human chromosome 14. J Med Genet 39:81-90.
23. Karlsson C, Stenman G, Vojta PJ, Bongcam-Rudloff E, Barrett JC, Westermark B, Paulsson Y. 1996. Escape from senescence in hybrid cell clones involves deletions of two regions located on human chromosome 1q. Cancer Res 56:241-245.
24. Knudson AG. 1985. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45:1437-1443.
25. Kuzmin I, Geil L, Ge H, Bengtsson U, Duh FM, Stanbridge EJ, Lerman MI. 1999. Analysis of aberrant methylation of the VHL gene by transgenes, monochromosome transfer, and cell fusion. Oncogene 18:5672-5679.
26. Kwong J, Lo KW, To KF, Teo PML, Johnson PJ, Huang DP. 2002. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 8:131-137.
27. Leone PE, Bello MJ, de Campos JM, Vaquero J, Sarasa JL, Pestana A, Rey JA. 1999. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas. Oncogene 18:2231-2239.
28. Lerman MI, Minna JD. 2000. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. Cancer Res 60:6116-6133.
29. Lo KW, Teo PML, Hui ABY, To KF, Tsang YS, Chan SYY, Mak KF, Lee JCK, Huang DP. 2000. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 60:3348-3353.
30. Lugo TG, Handelin B, Killary AM, Housman DE, Fournier REK. 1987. Isolation of microcell hybrid clones containing retroviral vector insertions into specific human chromosomes. Mol Cell Biol 7:2814-2820.
31. Lung ML, Choi CV, Kong H, Yuen PW, Kwong D, Sham J, Wei WI. 2001. Microsatellite allelotyping of Chinese nasopharyngeal carcinomas. Anticancer Res 21:3081-3084.
32. Malik K, Brown KW. 2000. Epigenetic gene deregulation in cancer. Br J Cancer 83:1583-1588.
33. Martin MD, Fischbach K, Osborne CK, Mohsin SK, Allred DC, O'Connell P. 2001. Loss of heterozygosity events impeding breast cancer metastasis contain the MTA1 gene. Cancer Res 61:3578-3580.
34. Mendonca MS, Howard K, Fasching CL, Farrington DL, Desmond LA, Stanbridge EJ, Redpath JL. 1998. Loss of suppressor loci on chromosome 11 and 14 may be required for radiation-induced neoplastic transformation of HeLa X skin fibroblast human cell hybrids. Radiat Res 149:246-255.
35. Mendonca MS, Desmond LA, Temples TM, Farrington DL, Mayhugh BM. 2000. Loss of chromosome 14 increases the radiosensitivity of CGL1 human hybrid cells but lowers their susceptibility to radiation-induced neoplastic transformation. Mutagenesis 15:187-193.
36. Mutirangura A, Tanunyutthawongese C, Pornthanakasem W, Kerekhanjanarong V, Sriuranpong V, Yenrudi S, Supiyaphun P, Voravud N. 1997. Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection. Br J Cancer 76:770-776.
37. Mutirangura A, Pornthanakasem W, Sriuranpong V, Supiyaphun P, Voravud N. 1998. Loss of heterozygosity on chromosome 14 in nasopharyngeal carcinoma. Int J Cancer 78:153-156.
38. O'Connell P, Fischbach K, Hilsenbeck S, Mohsin SK, Fuqua SAW, Clark GM, Osborne CK, Allred DC. 1999. Loss of heterozygosity at D14S62 and metastatic potential of breast cancer. J Natl Cancer Inst 91:1391-1397.
39. Pandit SD, Wang JC, Veile RA, Mishra SK, Warlick CA, Donis-Keller H. 1995. Index, comprehensive microsatellite, and unified linkage maps of human chromosome 14 with cytogenetic tie points and a telomere microsatellite marker. Genomics 29:653-664.
40. Robertson GP, Furnari FB, Miele ME, Glendening MJ, Welch DR, Fountain JW, Lugo TG, Huang HJS, Cavenee WK. 1998. In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma. Proc Natl Acad Sci USA 95:9418-9423.
41. Saxon PJ, Srivatsan ES, Leipzig GV, Sameshima JH, Stanbridge EJ. 1985. Selective transfer of individual human chromosomes to recipient cells. Mol Cell Biol 5:140-146.
42. Schwerdtle RF, Winterpacht A, Storkel S, Brenner W, Hohenfellner R, Zabel B, Huber C, Decker HJ. 1997. Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas. Cancer Res 57:5009-5012.
43. Srivatsan ES, Benedict WF, Stanbridge EJ. 1986. Implication of chromosome 11 in the suppression of neoplastic expression in human cell hybrids. Cancer Res 46:6174-6179.
44. Srivatsan ES, Ying KL, Seeger RC, 1993. Deletion of chromosome 11 and 14q sequences in neuroblastoma. Genes Chromosomes Cancer 7:32-37.
45. Srivatsan ES, Chakrabarti R, Zainabadi K, Pack SD, Benyamini P, Mendonca MS, Yang PK, Kang K, Motamedi D, Sawicki MP, Zhuang Z, Jesudasan RA, Bengtsson U, Sun C, Roe BA, Stanbridge EJ, Wilczynski SP, Redpath JL. 2002. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer. Oncogene 21:5631-5642.
46. Stanbridge EJ, Flandermeyer RR, Daniels DW, Nelson-Rees WA. 1981. Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids. Somat Cell Genet 7:699-712.
47. Sugawara O, Oshimura M, Koi M, Annab LA, Barrett JC, 1990. Induction of cellular senescence in immortalized cells by human chromosome 1. Science 247:707-710.
48. Szeles A, Yang Y, Sandlund AM, Kholodnyuk I, Kiss H, Kost-Alimova M, Zabarovsky ER, Stanbridge E, Klein G, Imreh S. 1997. Human/mouse microcell hybrid based elimination test reduces the putative tumor suppressor region at 3p21.3 to 1.6 cM. Genes Chromosomes Cancer 20:329-336.
49. Theobald M, Christiansen H, Schmidt A, Melekiar B, Wolkewitz N, Christiansen NM, Brinkschmidt C, Berthold F, Lampert F. 1999. Sublocalization of putative tumor suppressor gene loci on chromosome arm 14q in neuroblastoma. Genes Chromosomes Cancer 26:40-46.
50. Thiagalingam S, Laken S, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B, Lengauer C. 2001. Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc Natl Acad Sci USA 98:2698-2702.
51. Tomlinson IPM, Lambros MBK, Roylance RR. 2002. Loss of heterozygosity analysis: practically and conceptually flawed? Genes Chromosomes Cancer 34:349-353.
52. Weaver DA, Hei TK, Hukku B, DeMuth JP, Crawford EL, McRaven JA, Girgis S, Willey JC. 2000. Localization of tumor suppressor gene candidates by cytogenetic and short tandem repeat analyses in tumorigenic human bronchial epithelial cells. Carcinogenesis 21:205-211.
53. Yang Y, Kost-Alimova M, Ingvarsson S, Qianhui Q, Kiss H, Szeles A, Kholodnyuk I, Cuthbert A, Klein G, Imreh S. 2001. Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice. Proc Natl Acad Sci USA 98:1136-1141.
54. Young J, Leggett B, Ward M, Thomas L, Buttenshaw R, Searle J, Chenevix-Trench G. 1993. Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas. Oncogene 8:671-675.